Bubonic plague laboratory findings

Revision as of 23:41, 17 May 2014 by GeraldChi (talk | contribs)
Jump to navigation Jump to search

Bubonic plague Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Bubonic plague from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Bubonic plague laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Bubonic plague laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Bubonic plague laboratory findings

CDC on Bubonic plague laboratory findings

Bubonic plague laboratory findings in the news

Blogs on Bubonic plague laboratory findings

Directions to Hospitals Treating Bubonic plague

Risk calculators and risk factors for Bubonic plague laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Laboratory Findings

Human Specimens

Appropriate specimens should be examined for evidence of plague if a person resides in, or has a recent travel history to, plague-infected areas; has been bitten by fleas; and presents with symptoms suggestive of plague (fever, lymphadenopathy). Specimens should be obtained from appropriate sites for isolating the bacteria. The preferred specimen for microscopic examination and isolation from a bubonic case is material from the affected bubo, which should contain numerous organisms. Blood cultures should be taken whenever possible. Organisms may be seen in blood smears if the patient is septicemic, while blood smears taken from suspected bubonic plague patients are usually negative for bacteria. Bacteria may be intermittently released from affected lymph nodes into the bloodstream; therefore, a series of blood specimens taken 10-30 minutes apart may be productive in the isolation of Y. pestis. Sputum/throat smears taken from pneumonic plague patients may contain too many other organisms to be of diagnostic value if only Wayson stain is used; these smears should be stained as well with the more specific fluorescent-antibody (FA) test. Bronchial/tracheal washing should be taken from suspected pneumonic plague patients; throat specimens are not ideal for isolation of plague since they often contain many other bacteria that can mask the presence of plague. In cases where live organisms are unculturable, e.g., in specimens taken postmortem, lymphoid tissues, lung and bone marrow samples may yield evidence of plague infection by FA test or by detection of Y. pestis DNA. Specimens intended for culture should be taken before initiation of antibiotic treatment. Specimens are inoculated on general laboratory media and into laboratory mice for isolation; a thin smear is made from the remaining materials for examination by fluorescent microscopy. If a specimen is suspected to contain mixed flora, passage of the material through laboratory mice will increase the likelihood of recovery of a pure Y. pestis culture. Plague bacilli express a unique diagnostic envelope glycoprotein called the Fraction 1 (F1) antigen or capsular antigen at >33°C; this unique envelope antigen is the primary target antigen used for plague diagnostic FA and antibody tests. Plague bacilli are susceptible to lysis by a specific bacteriophage at both 25°C and 37°C. Plague bacilli are relatively inactive by standard enteric biochemical reactions; therefore, identification by biochemical profiles should be used as a supplemental diagnostic test. If a patient has been treated with a static antibiotic (e.g., tetracycline) for more than 4 days, bacterial cultures should be incubated for more than 5 days to give organisms a chance to recover. In case cultures yield negative results, serologic testing is advised. One serum specimen should be taken as early in the illness as possible to be followed by a second sample 1-4 months after antibiotic therapy has ceased.

Images

Animal/Flea Specimens

Likewise, appropriate tissues should be taken from animals for detection of Y. pestis. Lymphoid tissues should be removed for testing of the presence of F1 antigen by FA and by culture. Bone marrow from dessicated animal carcasses may yield positive results when other tissues are not available. In addition, serum and blood specimens may be taken for detection of antibody by agglutination. Fleas should be identified and may be placed in pools for tituration and examination. Titurated flea materials may be inoculated into laboratory mice for isolation of plague bacteria and for examination of mouse tissues by FA for expression of F1. Fleas or flea pool material may be directly examined by FA if the samples are pre-incubated at 37°C for 24 hours to encourage F1 antigen expression. The serum from inoculated laboratory mice may be examined for presence of antibody to F1. For serosurveillance of plague in animal populations, blood may be soaked and dried onto filter paper strips and sent to the laboratory for the detection of F1 antibody. Lastly, as with human specimens, in cases where no cultures or serum specimens are available for testing, both animal and flea material may be tested by polymerase chain reaction (PCR) to determine if plague DNA is present in the specimens.

Urinalysis

A urinalysis can also be useful for the determination of Y. Pestis. Urinalysis may show certain results such as:

There has also been the development of rapid urine dipsticks to test for the Y. Pestis antigen.

  • This type of development would be useful in the field if there were an outbreak for rapid identification.

References

Template:WikiDoc Sources